<DOC>
	<DOC>NCT01178853</DOC>
	<brief_summary>This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.</brief_summary>
	<brief_title>Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Subject is a healthy adult male or female volunteer aged 18 to 45 years, inclusive Subject has a body mass index of 18 to 32 kg/m2, inclusive Subject is able and willing to abstain from alcohol, grapefruit, caffeine Subject has no clinically relevant abnormalities on the basis of medical history, physical examination, and vital signs Subject has clinically relevant outofrange prothrombin time (PT), activated partial thromboplastin time, fibrinogen, protein C, or protein S Subject has abnormal prolongation of bleeding time at Screening Subject has hematuria on urinalysis Subject has personal or family history of coagulation or bleeding disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>